key: cord-0690705-4n9ijxkf
authors: Nelli, Rahul K.; Phadke, Kruttika-S; Castillo, Gino; Yen, Lu; Saunders, Amy; Rauh, Rolf; Nelson, William; Bellaire, Bryan H.; Giménez-Lirola, Luis G.
title: Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells
date: 2021-12-10
journal: Cell Death Discov
DOI: 10.1038/s41420-021-00781-w
sha: bc3468ced397ad8bc13c7edabf06d9b6c58eced9
doc_id: 690705
cord_uid: 4n9ijxkf

The ability of SARS-CoV to infect different species, including humans, dogs, cats, minks, ferrets, hamsters, tigers, and deer, pose a continuous threat to human and animal health. Pigs, though closely related to humans, seem to be less susceptible to SARS-CoV-2. Former in vivo studies failed to demonstrate clinical signs and transmission between pigs, while later attempts using a higher infectious dose reported viral shedding and seroconversion. This study investigated species-specific cell susceptibility, virus dose-dependent infectivity, and infection kinetics, using primary human (HRECs) and porcine (PRECs) respiratory epithelial cells. Despite higher ACE2 expression in HRECs compared to PRECs, SARS-CoV-2 infected, and replicated in both PRECs and HRECs in a dose-dependent manner. Cytopathic effect was particularly more evident in PRECs than HRECs, showing the hallmark morphological signs of apoptosis. Further analysis confirmed an early and enhanced apoptotic mechanism driven through caspase 3/7 activation, limiting SARS-CoV-2 propagation in PRECs compared to HRECs. Our findings shed light on a possible mechanism of resistance of pigs to SARS-CoV-2 infection, and it may hold therapeutic value for the treatment of COVID-19.

The ability to infect a wide variety of mammalian and avian species [1] , coronavirus (order Nidovirales, suborder Cornidovirineae, family Coronaviridae, subfamily Orthocoronavirinae) infections pose a recurring and continuous threat to human and animal health, particularly the new viral strains emerging from unknown wild animal reservoirs [2] [3] [4] . Historically, coronavirus infections in humans (e.g., those caused by HCoV-229E and HCoV-OC43 CoV strains) are mild and associated with only common cold symptoms [5] [6] [7] . However, the emergence of the betacoronaviruses, severe acute respiratory syndrome virus (SARS-CoV) (casefatality rate: 9.6%) [8, 9] , Middle East respiratory syndrome virus (MERS-CoV) (case-fatality rate: 34.4%) [10, 11] , and most recently, SARS-CoV-2 (case fatality rate: 2%) [12, 13] , the specific origin of which remains elusive and under continuous debate, have demonstrated the potential of coronaviruses to cause fatal disease in humans.

The COVID-19 pandemic highlights the importance of improving our understanding of how SARS-CoV-2 causes disease and spreads beyond humans. It also stimulated intensive research towards developing animal models, with a particular focus on the angiotensin-converting enzyme 2 (ACE2), which is the host cell receptor for SARS-CoV-2. Remarkably, different studies have demonstrated that several animal species, including dogs [14] , cats [15] , minks [16] , ferrets [17] , hamsters [18] , tigers [19] , and deer [20] , are susceptible to infection by SARS-CoV-2 through zooanthroponotic (or reverse-zoonotic) transmission [21] .

Interestingly, there is no known incidence of SARS-CoV-2associated disease in pigs, and different experimental studies in pigs have failed to show clinical signs and transmission between animals [14, [22] [23] [24] [25] . Former experimental studies in pigs showed no detection of viral RNA in nasal swabs or tissues nor seroconversion in response to SARS-CoV-2 inoculation [14, 22, 23] . However, a later study that used a higher inoculating dose than the previous studies reported mild pig susceptibility to SARS-CoV-2 as demonstrated by viral RNA and antibody detection in oral fluids and nasal wash in some inoculating pigs [25] . Moreover, Vergara-Alert and others observed SARS-CoV-2 neutralizing antibody response in pigs inoculated parenterally [24] , suggesting that pigs could be used as a model for viral immunogenicity studies. Understanding that host susceptibility is affected by many factors, and considering the complexity of reproducing infection under in vivo experimental conditions, current evidence suggests that pigs are comparatively less susceptible or more resistant to SARS-CoV-2 than humans and some other animal species (e.g., mink, deer) [16, 20] . However, the factors responsible for the lack of virus susceptibility or virus replication in pigs remain uninvestigated. This in vitro study evaluated differences in species-specific cell susceptibility to SARS-CoV-2, virus dose-dependent cytopathic effects, and infection kinetics between primary porcine and human respiratory epithelial cells expressing angiotensin-converting enzyme 2 (ACE2) receptor over the course of infection. In addition, we identified a potential mechanism for self-limiting SARS-CoV-2 infection in porcine respiratory epithelial cells.

Distribution of ACE2 receptor on porcine and human tracheal epithelial cells Immunohistochemistry (IHC) analysis of the ACE2 expression on tissue slides corresponded to normal adult human trachea tissue sections of commercially acquired slides indicated that ACE2 expression was predominantly present on epithelial cells, particularly towards the tracheal epithelial lining (Fig. 1A) . However, ACE2 expression was not observed in the subepithelial region of the trachea. In the pig tracheal section collected for this study, ACE2 was intermittently expressed on the epithelial cells, while its expression was predominantly observed on the epithelial lining of submucosal glands (Fig. 1C) . Even the subcultured primary cells isolated from human and pig tracheal epithelium showed evident expression of pan-cytokeratin and ACE2 (Fig. 1G ). However, a relative quantification of ACE2 expression by flow cytometric analysis, revealed that ACE2 expression level on PRECs was comparatively lower than that in HRECs (Fig. 1G ).

Deparaffinized and heat-retrieved (citrate buffer) tissue sections of human and pig trachea incubated overnight with heat-inactivated SARS-CoV-2 (USA-WA1/2020) showed evidence of virus attachment. In the human trachea, the virus appeared to be bound on both the epithelial and subepithelial regions ( Fig. 2A) , while the binding was more confined to the epithelial lining in the pig trachea (Fig. 2B ). In both human (Fig. 2C ) and pig ( Fig. 2D ) trachea, the secondary antibody controls showed minimal background staining. Meanwhile, HRECs (Fig. 2E) and PRECs (Fig. 2F ) inoculated with SARS-CoV-2 virus stock [dose multiplicity of infection (MOI) 5 .0] propagated in Vero-E6 cells showed positive brown staining for rabbit anti-SARS-CoV-2 N protein monoclonal antibody by IHC staining. The corresponding mock-inoculated controls (Fig. 2G , H) remained negative throughout the infection. Cells stained with secondary antibody control showed minimum background staining ( Fig. 2I-L) , and blank controls without primary and secondary antibodies ( Fig. 2M -P) were negative.

Both PRECs and HRECs cultures were SARS-CoV-2-inoculated with eight different viral doses (MOI 5.0, 5.0 × 10 −1 , 5.0 × 10 −2 , 5.0 × 10 −3 , 5.0 × 10 −4 , 5.0 × 10 −5 , 5.0 × 10 −6 , and 5.0 × 10 −7 ) or mockinoculated with inoculation medium, and incubated for 120 h post-inoculation (hpi). The average Ct values at the highest dose used (MOI 5.0) in HRECs and PRECs after 120 hpi were 15.5 and 17.5, respectively (Fig. 3A) . Approximately an average of three Ct increase (less virus) was detected for every 10-fold virus dilution until MOI 5.0 × 10 −5 , and the dilutions below MOI 5.0 × 10 −6 were near or above the threshold cut-off of 35 (Fig. 3A) .

Following infection, significant cytopathic changes such as rounding of cells, cell detachment, and vacuolation were observed by 72 hpi in both PRECs and HRECs. Overall, the cytopathic effects (CPE) increased with time, and SARS-CoV-2 infection in PRECs and HRECs is dose-dependent. The CPE was more evident at a high viral dose (MOI 5.0) by 72 hpi (Fig. 3B , E). Compared to HRECs, the cell death/cell detachment remarkably increased in PRECs at a viral dose of MOI 5.0 by 96 hpi (Fig. 3C , F) and continued through 120 hpi (Fig. 3D, G) . However, no significant differences in HRECs and PRECs death/cell detachment were noticed between viral doses MOI 5.0 × 10 −2 ( Fig. 3H-M) , 5.0 × 10 −4 ( Fig. 3N -S), and mock ( Fig. 3T-Y) . The cell detachment could be attributed to virusinduced cell death. Therefore, the potential role of apoptosis (nuclear fragmentation assay) and cytotoxicity (dual apoptosis/ toxicity assay) was examined in HRECs, and PRECS inoculated with SARS-CoV-2 at MOI 5.0 or mock-inoculated with culture medium, and incubated for 120 hpi. Cells stained with DAPI or hematoxylin revealed cell nuclear fragmentation only in SARS-CoV-2 infected PRECs (Fig. 4A) , while the nucleus remained intact in HRECs infected cells (Fig. 4B ) and mock-inoculated control cells from both species (Fig. 4C , D). Nuclear fragmentation is the hallmark feature in apoptotic cells. This finding was further confirmed using the ApoTox assay that measures cell viability, cytotoxicity, and apoptotic activity in the cells. The data of relative fluorescence/luminescence units obtained from HRECs and PRECs inoculated with SARS-CoV-2 were normalized against their respective mock-inoculated cell controls at each time point through the infection period. The positive controls ionomycin (Fig. 4E , F) and staurosporine (Fig. 4G ) performed as expected. The cell viability gradually decreased with time (12-96 hpi) in HRECs and PRECs inoculated with the virus (Fig.  4E) . However, the SARS-CoV-2-mediated decrease in cell viability observed in HRECs and PRECs following virus infection resulted in two different outcomes: HRECs infection was driven by a cytotoxicity-mediated mechanism (Fig. 4F) , while PRECs infection was mediated by apoptosis (Fig. 4G ).

To evaluate the SARS-CoV-2 viral replication kinetics in PRECs and HRECs culture supernatants from six replicates were collected at different time points (2, 12, 24, 48, 72 , 96, 120 hpi) for each inoculated viral dose and evaluated using a commercial SARS-CoV-2 N gene-based RT-qPCR assay. Based on the dose-response data previously presented herein, three different virus doses ( 

The potential infectivity of supernatants collected from HRECs and PRECs cultures previously infected (MOI 5.0) with SARS-CoV-2 was assessed on Vero-E6 cells. The virus replicated efficiently in Vero-E6 cells when cell culture supernatants collected at 96 hpi and 120 hpi from HRECs were used as inoculum (Fig. 6A, B) . In contrast, no virus replication was observed in Vero-E6 cells when the inoculum used was originated from PRECs previously infected with MOI 5.0 SARS-CoV-2 ( Fig. 6C, D) . Mock-inoculated supernatants collected from respective time points and cell types were used as controls ( Fig. 6E-H) . For staining controls, Vero-E6 treated with original stock (MOI 3.3) was used as a positive control (Fig. 6I) , and mock inoculation media was used as a negative control (Fig. 6J ).

The ongoing global pandemic of SARS-CoV-2 has resulted in different clinical outcomes in two closely related mammalian species, humans and pigs. While in humans, the COVID-19 pandemic has resulted in >4.5 million deaths across the world (>223 million confirmed cases; as of 09/10/2021) [26] , pigs, in contrast, and according to previous reports, seem to be either not susceptible to SARS-CoV-2 infection [14, 22, 23] or where the infection is mild and self-limited [25] . The successful reproduction of infection and clinical disease in vivo under experimental settings can be difficult in pigs, even with swine-restrictive viruses. Constraints include resource-intensive, susceptibility-related factors, inoculum dose and route of exposure, high variability, lack of sensitivity, interference with gut microbiome or secondary infections, and difficulty recording precise cell-viral interactions on a daily/hourly basis. In contrast, in vitro, culture models based on cell lines are relatively easy to maintain, but often they are not the natural cell target of the virus, nor do they represent sufficient complexity (cell lineage, functionality) to mimic the natural infection process in vivo [27] . For this reason, in vitro experimental data cannot often be extrapolated into clinical trials entirely, e.g., complicated cellular signals between cells and their matrix cannot be reproduced [28] . This would justify using primary respiratory epithelial cell cultures to understand the immunopathogenesis of SARS-CoV-2.

Tracheobronchial-derived primary epithelial cells have been widely used to study early immune responses towards viral infections [29] [30] [31] [32] . Thus, the first objective of this study was to confirm whether porcine respiratory epithelial cells were susceptible to infection by SARS-CoV-2 and comparing it with human respiratory epithelial cells.

Using ACE2 as entry receptor and proteases as entry activators [33] , SARS-CoV-2 spike protein mediates virus entry into the respiratory epithelial cells of a susceptible host, where the virus primarily replicates [34, 35] . Previous studies reported the detection of viral antigens in the human trachea, bronchi, bronchiole, and pneumocytes [36] tracheal degeneration and necrosis in affected cats [14] , alveolar damage and necrosis in minks [37] , and detection of viral RNA in the bronchi of white tailed-deer [20] .

First, the present study demonstrated the expression of ACE2 receptor and effective SARS-CoV-2 binding on the epithelial lining of both human and pig tracheal tissue sections, which contradicts a previous study that hypothesized that the lack of virus susceptibility or virus replication could be attributed to the absence of ACE2 receptors on the porcine respiratory tract epithelium [38] . This finding is supported by a recent study showing that ACE2 is expressed, at different levels, in a wide range of porcine tissues, including the lungs [39] .

In our study, a human ACE2 antibody was used for IHC analysis on both human and pig trachea tissue sections and primary respiratory cells. The expression levels of ACE2 were significantly low on pig tracheal epithelium tissue sections compared to their human counterparts (Fig. 1A, C) . Further, flow cytometric analysis of isolated PRECs and HRECs quantified the amount of both pan- cytokeratin and ACE2 expressed on these cell types, confirming that human cells expressed more ACE2 than pig cells. Despite the paucity in ACE2 expression on pig trachea, heat-inactivated SARS-CoV-2 bound uniformly across the pig and human trachea tracheal epithelium ( Fig. 2A, B) . The protein sequence homology studies between human ACE2 (NP_001358344) and pig ACE2 (NP_001116542) performed in this study and others [40] suggest that these closely related mammalian species share 81% identical amino acid residues. Further, a pair-wise alignment of porcine ACE2 protein with human ACE2 protein at the region targeted by the anti-ACE2 antibody (amino acids 631-805; sc-390851, Santa Cruz Biotechnology) used in this study shows a sequence similarity of 76% ( Supplementary Fig. 1) , suggesting the potential cross-reactivity and usefulness of anti-ACE2 antibody towards detection of porcine ACE2 receptor in tissues and cultures.

After confirming the expression of ACE2 receptors in human and pig tracheobronchial-derived tissue sections and cells, we performed a comparative in vitro infection study to investigate possible factors related to possible differences in the susceptibility of primary porcine and human tracheobronchial epithelial cells to SARS-CoV-2 infection. Firstly, the optimal viral dose in PRECs and HRECs cultures was established for subsequent infection studies. As to the question of whether SARS-CoV-2 can infect and replicate in PRECs, SARS-CoV-2 replicated in both PRECs and HRECs in a dose-dependent manner, as evidenced by RT-qPCR and IHC assays (Fig. 3) . Virus replication was monitored in PRECs and HRECs cultures inoculated with three different infectious doses (MOI 5.0, 5.0 × 10 −2 , and 5.0 × 10 −4 ) over 120 hpi period. SARS-CoV-2 N protein was gradually accumulated in both PRECs and HRECs cultures as infection progressed, particularly at the higher infectious dose (MOI 5.0) used in this study. The CPE was particularly evident in PRECs compared to HRECs or the corresponding mock-inoculated controls. This CPE was dose-and time-dependent, dramatically enhanced in PRECs at MOI 5.0 infectious dose and 96 hpi (Fig. 3E-G) . This strongly indicates that virus dose is a potential factor in the outcome of SARS-CoV-2 infection in these primary cells, as it was previously hypothesized [41] . Previous in vivo studies in pigs demonstrated that only using a high infectious dose (2 mL of approximately 10 6 TCID50/mL intranasally and intratracheally) triggered the production of anti-SARS-CoV-2 neutralizing antibodies even in the absence of clinical signs [24, 25] .

Subsequently, we investigated the overall mechanism behind the CPE and massive cell death particularly observed in PRECs cultures inoculated with the higher infectious dose (MOI 5.0) evaluated in this study. In general, CPE and cell death could be either cell-associated (i.e., cells died because of their inability to reproduce) or virus-induced (i.e., lysis and dissolution caused by virus infection). This can be elucidated on the basis of general morphological, biochemical, and functional features [42] .

Specifically, morphological analysis of SARS-CoV-2 infected PRECs cultures revealed all the hallmark morphological signs of apoptosis, a controlled form of cell death [42] , including cell shrinkage and detachment, plasma membrane blebbing, the formation of apoptotic bodies, chromatin condensation (pyknosis), and nuclear fragmentation (karyorrhexis) leading to cell death (Fig. 5C ). In contrast, in HREC cultures, most cells were attached to the plate and appeared viable with no notable differences in the morphology of the nucleus between SARS-CoV-2-and mockinoculated cultures (Fig. 5A, B) .

On the other hand, the genetic and biochemical cell-death analysis includes activation of cysteine aspartate-specific proteinases (caspases) and releasing mitochondrial factors as crucial features of the apoptotic process [42] . Using the biochemical ApoTox-Glo triplex assay, we further demonstrated an early and enhanced apoptotic mechanism mediated through caspase 3/7 activation in response to SARS-CoV-2 infection in PRECs compared to HRECs. The decrease in cell viability was particularly high in SARS-CoV-2 infected PRECs after 48 hpi (Fig. 4G) . Contrary, the expression levels of caspase 3/7 in HRECs infected cultures remained stable throughout the infection period. Additional SARS-CoV-2 infection studies on human bronchial epithelial cells (BEAS-2B) also reported no induction of apoptosis [43] . Interestingly, SARS-CoV-2 induced enhanced cytotoxicity in HRECs compared to PRECs cultures after 48 hpi (Fig. 4F ). In addition, the supernatants collected from HRECs infected with SARS-CoV-2 contained infectious virions that were able to infect Vero-E6 cells, while the corresponding supernatants from PRECs undergo apoptosis lacked viable virus and were, therefore, non-infectious. In 2012, Nelli and others reported comparable findings in primary human and porcine respiratory epithelial cells infected with highly pathogenic H5N1 influenza A virus (IAV) [31, 44] .

The results of the present study demonstrated that an early onset of apoptosis via caspase 3/7 activation is a crucial event to limit SARS-CoV-2 propagation in PRECs. Thus, further research on modulation of apoptosis and the effect of caspase inhibitors is needed. The early apoptotic cell death observed in PRECs may favor the host cell, while the delayed cell death observed in HRECs may favor the virus. Previous experimental studies in vivo observed complete virus (RNA) clearance one week after virus inoculation in pigs [45] . This, together with additional studies reporting absence of clinical signs and effective virus transmission between animals [14, [22] [23] [24] [25] , led to conclude that pigs are more resistant to SARS-CoV-2 infection than humans and other animal species such as cats, mink and deer.

Taken together, our findings shed light on the possible molecular mechanism of resistance of pigs to SARS-CoV-2 infection and/or virus propagation, and it may hold therapeutic value for the treatment of COVID-19.

All infection experiments involving SARS-CoV-2 were performed in the BSL-3 laboratory facilities at Iowa State University (ISU) under pre-established/ approved protocols.

Tissues from the tracheal region of the respiratory tract, i.e., from below the larynx to the bronchial bifurcation (approx. 6-8 inches), were aseptically collected from 7-day-old healthy cesarean-derived, colostrum-deprived (CD/CD) pigs (Yorkshire x Large White crossbred, Struve Labs International, Inc., Manning, IA, USA) immediately after necropsy. The experimental protocol for porcine sample collection was approved by the Institutional Animal Care and Use Committee (IACUC log# 12-17-8658-S; approval date: January 3, 2018) at ISU. Briefly, piglet tracheal sections were collected in Dulbecco's Minimum Essential / Ham's F-12 medium with GlutaMAX (DMEM/F-12) (Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 100 IU/mL of penicillin/100 µg/mL of streptomycin (Pen-Strep) (Thermo Fisher Scientific), and 1.25 µg/mL of amphotericin B (AmpB) (Thermo Fisher Scientific) for isolation of PRECs as previously described [32] . Tracheal samples were washed and incubated in phosphate-buffered saline (PBS) pH 7.4 supplemented with Pen-Strep to remove any blood 

Both isolated primary PRECs and commercially acquired HRECs (ATCC, PCS-300-010, Lot-70002486) were subcultured on cell/tissue culture flasks or plates (Greiner Bio-One North America Inc, Monroe, NC, USA), pre-coated with PureCol ® Type I collagen (40 µg/mL/4 mm 2 ; Advanced BioMatrix, Inc., San Diego, CA, USA), at a density of~20,000 cells/ cm 2 . Both PRECs and HRECs were propagated in ATCC airway epithelial cell basal medium (ATCC ® PCS-300-030™) supplemented with 500 mg/mL HSA, 0.6 mM linoleic acid, 0.6 mg/mL lecithin, 6 mM L-Glutamine, 0.4% Extract P, 1.0 mM epinephrine, 5 mg/mL transferrin, 10 nM 3,3′,5-Triiodo-L-thyronine (T3), 5 mg/mL hydrocortisone, 5 ng/mL rh epidermal growth factor (EGF), 5 mg/mL rh insulin, Pen-Strep and Amp-B (growth media). Cells were dissociated with 0.5X TrypLE TM express enzyme (Thermo Fisher Scientific) and neutralized using 50% heat-inactivated FBS (EquaFetal™, Atlas Biologicals), mixed in LHC basal medium (Thermo Fisher Scientific). Specifically, primary cells used in this study corresponded to passage 16 for PRECs and 9 for HRECs.

Vero-E6 cells (ATCC, CRL-1586) were used to propagate SARS-CoV-2 (the following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281) according to CDC protocol [46] . In brief, cells were sub-cultured in DMEM (Corning, Tewksbury, MA, USA) supplemented with 10% FBS. After culturing the trypsinized cells for 24 h, the cells were treated with SARS-CoV-2 virus at 0.05 plaque-forming units (PFU)/cell. The inoculated cultures were then incubated at 37°C in humidified 5% CO 2 incubator and observed for viral replication and CPE daily. Viral supernatants were collected from culture flasks showing CPE greater than 90%, and after removing the cell debris, the virus titer in the supernatants was determined by plaque assay in Vero-E6 cells. After propagating for 3 passages, approximately 10 7 PFU/mL of virus titer was achieved, which were aliquoted and frozen at −80°C for subsequent virus infectious studies on HRECs and PRECs.

For virus titration assays, 20,000 (Vero-E6/ HRECs/ PRECs) cells were seeded per well in a 96-well plate. In both PRECs and HRECs, before the day of Vector Laboratories) was used as per the manufacturer's instructions. In brief, sections/cells blocking with animal-free buffer (Vector Laboratories) for 30 min and incubated overnight with the corresponding mouse or primary rabbit antibody at 4°C. The tissues were treated with 0.1% hydrogen peroxide for 1 h, while cells were treated for 5 min, followed by incubation with the respective secondary antibody for 60 min. Chromogenic detection in situ was performed using ImmPACT DAB EqV peroxidase substrate solution (Vector Laboratories) and hematoxylin, followed by mounting (tissue sections only) in Tissue-Tek Glas mounting medium (Sakura Finetek). Microscopic images were captured using Olympus ® CKX4 microscope (Olympus ® Corp., Center Valley, PA USA), Infinity 2 camera, and Infinity Analyze imaging software (Ver 6.5.5, Lumenera Corp, Ottawa, ON, Canada).

Confluent monolayers of HRECs and PRECs were trypsinized as described earlier, and dissociated cell suspension was incubated in PBS containing 100 μg/mL bovine deoxyribonuclease I (MilliporeSigma, St. Louis, MO, USA) and 5 mM magnesium chloride (MilliporeSigma) for 15 min at room temperature. After incubation, the cell suspension was passed through a 30 μm cell strainer (Miltenyi Biotec, Bergisch Gladbach, Germany), and cells were washed thoroughly by centrifuging at 200 x g for 5 min. Flow cytometric staining was performed using a cell concentration of approximately 200,000 cells per treatment in FACS buffer (PBS supplemented with 1% FBS and 0.09% sodium azide). After a 30 min incubation step on the ice, and washing twice with FACs buffer, the cells were stained with LIVE/DEAD™ Fixable Near-IR Dead Cell Stain Kit (Thermo Fisher Scientific) at a previously determined concentration of 1:200. For revealing ACE2 receptor expression, cells were stained with mouse anti-ACE2 (Santa Cruz Biotechnology) and fixed with BD Cytofix/Cytoperm™ solution (BD Biosciences, San Jose, CA, USA) for 20 min on ice. For assessing the pancytokeratin expression, fixed cells were permeabilized with Perm/Wash™ buffer (BD Biosciences) for 30 min on ice, washed and stained for mouse anti-pan-cytokeratin (Bio-Rad Laboratories). Then, after 30 min incubation on ice with a goat anti-mouse labeled to Alexa Fluor ® 647 (15 μg/mL, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA), the cells were washed twice and resuspended into 200 μL FACS buffer. Samples were analyzed on Attune NxT flow cytometer equipped with an autosampler (Thermo Fisher Scientific) as per manufacturer protocols, using appropriate threshold and gate settings. Each experiment samples tested in duplicate, including unstained, FMO, and isotype controls. Compensation controls were also performed, and the corresponding data were analyzed.

Human and pig tracheal epithelial sections were incubated overnight at 37 o C with 250 μL of heat-inactivated SARS-CoV-isolate USA-WA1/2020 (the following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Heat Inactivated, NR-52286) at 37°C in a humidified chamber. After overnight incubation with the virus, the tissue sections were vigorously washed with TBST for 15 min, and the IHC staining was performed as described in the previous section.

Viral RNA extractions were performed using the E.Z.N.A. ® Viral RNA Kit (Omega Bio-tek, Inc., Norcross, GA, USA) and the vacuum manifold (QIAGEN, Germantown, MD, USA) method following the'manufacturer's instructions. A SARS-CoV-2 viral N gene-based RT-qPCR developed and commercialized by Tetracore (Tetracore, Inc., Rockville, MD, USA) was used in this study as per recommended instruction manual and was modified for the use of the Rotor-Gene Q with the help of Tetracore. Each 25 μL RT-qPCR reaction contained: 16.75 μL EZ-SARS-CoV-2 Mastermix which included primers-probes for FAM-SARS-CoV-2, TAMRA-inhibition control in vitro transcript, Cy5-human RNase P; 0.5 μL inhibition control; 0.75 μL of enzyme; 7 μL of the extracted sample RNA. All RT-qPCR reactions included two positive controls, one supplied by the manufacturer and the other obtained through BEI Resources, NIAID, NIH (the following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH; qPCR control RNA from heat-inactivated SARS-CoV-2 (isolate USA-WA1/2020, NR 52347), and a ""no template"" control (NTC). RT-qPCR reactions were run on a Rotor-Gene Q (QIAGEN) with cycling conditions, 48°C for 15 min and 95°C for 2 min holding; 40 cycles, 95°C for 10 s denaturation, and 60°C for 40 s amplification. The RT-qPCR results were analyzed using Rotor-Gene Q Pure Detection software (v 2.3.1). For this study, samples with a threshold cycle (Ct) above 35 were considered negative.

Paraformaldehyde (4%) fixed SARS-CoV-2 and mock-inoculated cells were permeabilized with 0.1% Triton X-100 for 10 min. Next, nuclear staining was performed using two drops/mL NucBlue fixed cell ReadyProbes reagent with '4', 6-diamidino-2 phenylindole (DAPI) (Thermo Fisher Scientific) in PBS and incubated for 5 min at room temperature. After washing thrice with PBS, microscopic images were captured using fluorescent microscopy (Olympus ® CKX4 microscope, Infinity 2 camera, and Infinity Analyze imaging software).

The ApoTox-Glo™ Triplex Assay was used to assess the differences in cell death status (i.e., cell viability, cytotoxicity, and apoptosis) between HRECs and PRECs over the course (96 h) of SARS-CoV-2 infection. The live-cell protease activity restricted to intact viable cells was measured using a fluorogenic (400Ex/505Em; Viability), cell-permeant, peptide substrate (glycyl-phenylalanyl-aminofluorocoumarin; GF-AFC). A fluorogenic (485Ex/ 520Em; Cytotoxicity) cell-impermeant peptide substrate (bis-alanylalanylphenylalanyl-rhodamine 110; bis-AAF-R110) was used to measure deadcell protease activity. A luminogenic caspase-3/7 substrate containing the tetrapeptide sequence DEVD is a reagent optimized for caspase activity, luciferase activity, and cell lysis was used to evaluate apoptosis. The cleavage of the inactive form of caspase to active caspases resulted in the luminescence signal produced by luciferase, which was proportional to the amount of caspase activity (apoptosis) present.

After seeding 15,000 cells per 96-well flat clear bottom black polystyrene surface-treated microplates (CellBind ® ; Corning), cells were inoculated with R.K. Nelli et al.

MOI 5.0 SARS-CoV-2 and mock controls and incubated for 12, 24, 48, 72, and 96 h, respectively. The ApoTox-Glo™ Triplex assay was performed as per manufacturer protocol. In brief, 20 μL of Viability/Cytotoxicity reagents containing both GF-AFC and bis-AAF-R110 substrates were added to all wells and mixed well and incubated for 30 min at 37°C. Fluorescence was measured at two different wavelength sets. For caspase 3/7 activity, 100 μL of Caspase-Glo ® 3/7 reagent was added to all wells and mixed well and incubated for 30 min at room temperature, and the luminescence was immediately measured. Predetermined concentrations of staurosporine (0.625 μM; apoptosis control; Cayman Chemicals, Ann Arbor, MI, USA) and ionomycin (25 μM; viability and cytotoxicity control; Cayman Chemicals) as positive control were added to cell control wells 6 h before start recording the measurements at each time point. Measurements in all samples, i.e., infected, mock, and positive controls treated cells, were recorded in a POLARstar Omega microplate reader (BMG Labtech microplate reader BMG Labtech Inc., Cary, NC, USA).

Statistical analyses and plots were performed using the data from flow cytometry, RT-qPCR, and ApoTox-Glo™ Triplex assays and analyzed using GraphPad Prism ® 9.0.2 software and Microsoft Excel. The statistical significance was determined using the two-way ANOVA multiple comparisons of Fisher's least significant difference (LSD) test. For all analyses, a p-value <0.05 was considered statistically significant.

Methods and Protocols

Deltacoronavirus evolution and transmission: current scenario and evolutionary perspectives

Analysis of possible intermediate hosts of the new coronavirus SARS-CoV-2

Ranking the risk of animal-to-human spillover for newly discovered viruses

The time course of the immune response to experimental coronavirus infection of man

Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)

Coronavirus as a possible cause of severe acute respiratory syndrome

SARS cases with onset of illness from 1

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

A novel coronavirus from patients with pneumonia in China

COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Transmission of SARS-CoV-2 in domestic cats

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Infection and rapid transmission of SARS-CoV-2 in ferrets

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

From people to panthera: natural SARS-CoV-2 infection in tigers and lions at the Bronx Zoo

Susceptibility of White-Tailed Deer (Odocoileus virginianus) to SARS-CoV-2

Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: a case study of bats

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study

Susceptibility of swine cells and domestic pigs to SARS-CoV-2

Pigs are not susceptible to SARS-CoV-2 infection but are a model for viral immunogenicity studies

Susceptibility of domestic swine to experimental infection with severe acute respiratory syndrome coronavirus 2

COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data

The genome landscape of the African Green monkey kidney-derived vero cell line

Three-dimensional cell culture: a breakthrough in vivo

Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia

Distinct infection process of SARS-CoV-2 in human bronchial epithelial cell lines

Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release

Porcine hemagglutinating encephalomyelitis virus infection in vivo and ex vivo

Cell entry mechanisms of SARS-CoV-2

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus

Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks

SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species

Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2

Describing variability in pig genes involved in coronavirus infections for a One Health perspective in conservation of animal genetic resources

COVID-19: does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics? Med Hypotheses

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death

Cell-type apoptosis in lung during sars-cov-2 infection

Molecular host response to influenza virus infections in primary pig and human cells

Susceptibility of pigs and chickens to SARS coronavirus

Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient. bioRxiv: the preprint server for biology

The authors would like to thank Dr Rodger Main for his generous support in obtaining various SARs-CoV-2 reagents from Biodefense and Emerging Infections (BEI) Research Resources Repository. We appreciate the contributions and guidance of Dr James A Roth.

The original contributions presented in the study are included in the article/ supplementary material, further inquiries can be directed to the corresponding author.

The authors declare no competing interests.

The study was performed in accordance with Iowa State University's office of research ethics.

Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41420-021-00781-w.Correspondence and requests for materials should be addressed to Luis G. Giménez-Lirola.Reprints and permission information is available at http://www.nature.com/ reprintsPublisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/.